Is Equinox Gold (EQX) Stock Outpacing Its Basic Materials Peers This Year? — Positive
EQX Zacks Investment Research — April 25, 2025Here is how Equinox Gold (EQX) and B2Gold (BTG) have performed compared to their sector so far this year.
Are Investors Undervaluing Banco Santander Chile (BSAC) Right Now? — Positive
BSAC Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Industrial Products Stocks Lagging DXP Enterprises (DXPE) This Year? — Negative
DXPE Zacks Investment Research — April 25, 2025Here is how DXP Enterprises (DXPE) and Insteel Industries (IIIN) have performed compared to their sector so far this year.
Is OFG Bancorp (OFG) a Great Value Stock Right Now? — Positive
OFG Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Synchrony (SYF) is a Strong Value Stock — Positive
SYF Zacks Investment Research — April 25, 2025The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing Chemung Financial Corp (CHMG) Right Now? — Positive
CHMG Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? — Positive
BSX Zacks Investment Research — April 25, 2025Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Is Medallion Financial (MFIN) Stock Undervalued Right Now? — Positive
MFIN Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Epsilon Energy (EPSN) Outperforming Other Oils-Energy Stocks This Year? — Positive
EPSN Zacks Investment Research — April 25, 2025Here is how Epsilon Energy Ltd. (EPSN) and Ultrapar Participacoes S.A.
Should Value Investors Buy Orix Corp Ads (IX) Stock? — Positive
IX Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Tenet Healthcare (THC) Stock Undervalued Right Now? — Positive
THC Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Computer and Technology Stocks Lagging CyberArk Software (CYBR) This Year? — Negative
CYBR Zacks Investment Research — April 25, 2025Here is how CyberArk (CYBR) and Amphenol (APH) have performed compared to their sector so far this year.
Is Kinross Gold (KGC) a Great Value Stock Right Now? — Positive
KGC Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy POSCO (PKX) Stock? — Positive
PKX Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy City Office REIT (CIO) Stock? — Positive
CIO Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing ADT (ADT) Right Now? — Positive
ADT Zacks Investment Research — April 25, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Teck Resources Q1 Earnings Beat Estimates, Sales & Margins Improve Y/Y — Positive
TECK Zacks Investment Research — April 25, 2025TECK delivers solid improvement in Q1 revenues, adjusted EBITDA and earnings, on high sales volumes and prices.
Here's Why Agnico Eagle Mines (AEM) is a Strong Growth Stock — Positive
AEM Zacks Investment Research — April 25, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Class Action Filed Against Zenas BioPharma, Inc. (ZBIO) Seeking Recovery for Investors - Contact Levi & Korsinsky — Neutral
ZBIO Accesswire — April 25, 2025NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=145098&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Lawsuit - VTRS — Neutral
VTRS Accesswire — April 25, 2025NEW YORK, NY / ACCESS Newswire / April 25, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=145099&wire=1 or contact Joseph E. Levi, Esq.
